FDA Announces Proposed Collection of Information for Electronic Drug Product Reporting

Summary

The Food and Drug Administration (FDA) is announcing a proposed collection of information for review and clearance under the Paperwork Reduction Act of 1995, specifically for electronic reporting of human drug compounding outsourcing facilities under Section 503B of the Federal Food, Drug, and Cosmetic Act.